Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
ICD-10 C77.5 is a billable code used to indicate a diagnosis of secondary and unspecified malignant neoplasm of intrapelvic lymph nodes.
C77.5 refers to secondary malignant neoplasms that have metastasized to the intrapelvic lymph nodes. This condition typically arises from a primary cancer located elsewhere in the body, such as the breast, prostate, or gastrointestinal tract. The lymphatic system serves as a pathway for cancer cells to spread, leading to the involvement of lymph nodes in the pelvis. The diagnosis of C77.5 is often made through imaging studies, such as CT scans or MRIs, and confirmed via biopsy. Patients may present with symptoms related to the primary malignancy or may be asymptomatic. The staging of metastatic disease is crucial, as it influences treatment decisions and prognosis. Palliative care considerations are significant for patients with C77.5, focusing on symptom management and quality of life, especially in advanced stages where curative treatment is not feasible. Accurate coding requires thorough documentation of the primary site, staging, and any treatments administered.
Detailed history of the primary malignancy, staging information, and treatment plans.
Patients with known primary cancers presenting with lymphadenopathy in the pelvis.
Ensure accurate staging and documentation of any palliative care interventions.
Comprehensive symptom management plans and patient quality of life assessments.
Patients with advanced cancer requiring symptom relief and supportive care.
Focus on documenting the impact of metastatic disease on patient well-being.
Used when a biopsy confirms metastatic disease in the lymph nodes.
Pathology report confirming malignancy and site of origin.
Oncologists should ensure that biopsy results are clearly linked to the diagnosis.
Coding C77.5 accurately reflects the presence of metastatic disease in the intrapelvic lymph nodes, which is essential for treatment planning and understanding the patient's prognosis.
